PerkinElmer buys preclinical imaging firm
This article was originally published in The Gray Sheet
Executive Summary
Diversified diagnostics and analytical instrumentation company is acquiring in vivo molecular imaging firm VisEn Medical to expand its technologies "downstream into preclinical research undertaken in academic institutes and pharmaceutical companies." Bedford, Mass.-based VisEn makes fluorescence molecular imaging systems and reagents for use in the research of cancer, inflammation, cardiovascular, skeletal and pulmonary diseases. Financial terms of the deal, announced Aug. 3, were not disclosed
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.